Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Accepts Amgen's Supplemental Biologics License Application to Expand Indication for Xgeva to Inc

americanpharmaceuticalreviewJune 22, 2017

Tag: Multiple Myeloma Patients , FDA

PharmaSources Customer Service